6

Invesco NASDAQ Biotech ETF
Ordredybde
Generel information
Årlig omkostning
0,40%Aktivklasse
AktieKategori
Sektor - Bioteknologi, AktierBasisvaluta
EURUdbyttepolitik
AkkumulerendeFaktaark
The investment objective of the Fund is to achieve the total return performance of the NASDAQ Biotechnology Index (the "Reference Index") less fees, expenses and transaction costs. The Reference Index is designed to represent the performance of biotechnology and pharmaceutical securities on the NASDAQ Stock Market®.
Relaterede ETFer
Eksponering
Fordeling
- Aktier100%
Andre har kigget på
Debat
Nyheder
Generel information
Årlig omkostning
0,40%Aktivklasse
AktieKategori
Sektor - Bioteknologi, AktierBasisvaluta
EURUdbyttepolitik
AkkumulerendeFaktaark
The investment objective of the Fund is to achieve the total return performance of the NASDAQ Biotechnology Index (the "Reference Index") less fees, expenses and transaction costs. The Reference Index is designed to represent the performance of biotechnology and pharmaceutical securities on the NASDAQ Stock Market®.
Relaterede ETFer
Nyheder
Ordredybde
Eksponering
Fordeling
- Aktier100%
Andre har kigget på
Debat
Generel information
Årlig omkostning
0,40%Aktivklasse
AktieKategori
Sektor - Bioteknologi, AktierBasisvaluta
EURUdbyttepolitik
AkkumulerendeFaktaark
The investment objective of the Fund is to achieve the total return performance of the NASDAQ Biotechnology Index (the "Reference Index") less fees, expenses and transaction costs. The Reference Index is designed to represent the performance of biotechnology and pharmaceutical securities on the NASDAQ Stock Market®.
Relaterede ETFer
Nyheder
Debat
Ordredybde
Eksponering
Fordeling
- Aktier100%
